Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00004885
What this trial is testing

Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 430
Testing effectiveness (Phase 2)UnknownNCT00075738
What this trial is testing

Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicableStudy completedNCT03542097
What this trial is testing

Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan

Who this might be right for
Ewing Sarcoma Family of Tumors
Istituto Ortopedico Rizzoli 82
Testing effectiveness (Phase 2)Study completedNCT01853813
What this trial is testing

First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage II
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 85
Early research (Phase 1)Ended earlyNCT02283359
What this trial is testing

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
H. Lee Moffitt Cancer Center and Research Institute 3
Early research (Phase 1)Study completedNCT01822613
What this trial is testing

Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Novartis Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT00689624
What this trial is testing

Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital of Crete 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05843188
What this trial is testing

Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Health Network, Toronto 155
Large-scale testing (Phase 3)UnknownNCT00168896
What this trial is testing

Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Who this might be right for
Small Cell Lung Cancer
Charite University, Berlin, Germany 286
Testing effectiveness (Phase 2)Study completedNCT00419159
What this trial is testing

Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy

Who this might be right for
Colorectal Cancer
Novartis Pharmaceuticals 199
Testing effectiveness (Phase 2)Study completedNCT04752696
What this trial is testing

Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Cardiff Oncology 41
Testing effectiveness (Phase 2)Ended earlyNCT00053833
What this trial is testing

S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
SWOG Cancer Research Network 2
Testing effectiveness (Phase 2)Ended earlyNCT00263016
What this trial is testing

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sanofi 50
Early research (Phase 1)Study completedNCT00364143
What this trial is testing

Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors

Who this might be right for
Cancer
Yakult Honsha Co., LTD 40
Testing effectiveness (Phase 2)Study completedNCT00005626
What this trial is testing

Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)

Who this might be right for
LeukemiaLymphoma
H. Lee Moffitt Cancer Center and Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT00104793
What this trial is testing

Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Japan Multinational Trial Organization 55
Testing effectiveness (Phase 2)Looking for participantsNCT06827717
What this trial is testing

Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Sun Yat-sen University 29
Testing effectiveness (Phase 2)Study completedNCT00048126
What this trial is testing

Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 57
Testing effectiveness (Phase 2)Study completedNCT00832689
What this trial is testing

Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Yonsei University 39
Testing effectiveness (Phase 2)Study completedNCT00066274
What this trial is testing

Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
UNICANCER
Next Page